SMALTIS joins the Biotech Investissement Group!

Publication date : 2019-08-28

We are pleased to announce the entry of Biotech Investissement into the capital of SMALTIS SAS, a company based in Besançon (France), which joins RD-Biotech SAS, Diaclone SAS, SynAbs SA and QVQ Holding within the group (

Created in 2014, SMALTIS ( has a solid expertise in Microbiology and an innovative experience in Bacterial Genetics. Thanks to its know-how, SMALTIS designs tailor-made methods and delivers mutant bacteria with high added value for the development, manufacturing and quality control stages of health products. The company is now specialized in three major activities related to public health challenges: Antibiotic resistance and infection control, exploration of Microbiota and engineering Bacterial Mutants.

By joining the Biotech Investissement group, SMALTIS is consolidating already well-established expertise in the fields of Bioproduction and related quality controls, by adding Microbiological and Bacterial Genetic Engineering expertise.

Contact :

Other news

  • Promo d'été
    Promo d'été sur la gamme ELISpot
    Publication date : 2019-07-04
    Profitez d’une remise de 20% sur les produits ELISpot! Read more
  • Diaclone recrute!
    Diaclone is recruting !
    Publication date : 2019-08-28
    As part of its development, Diaclone is recruiting an international Sales & Marketing manager based in Besancon, France. Read more
  • Assays for the Human IL-17 Family
    DIACLONE Assays for the Human IL-17 Family
    Publication date : 2019-08-28
    Diaclone has developed a large range of ELISA and ELISpot kits for the detection of Human IL-17A, IL-17F and IL-17A/F. Read more
  • PSL
    PSL Alliance
    Publication date : 2019-08-28
    Diaclone is a core member of the PSL Alliance Read more
    The CAM family: A new target for monitoring or treating cancers?
    Publication date : 2019-08-28
    The cell adhesion molecules (CAMs) family includes more than 50 proteins with four main groups: immunoglobulin (Ig)-like CAMs, cadherins, selectins, and integrins. Read more
  • Biocitech
    4th edition of “Bioproduction des Immunothérapies"
    Publication date : 2019-08-28
    DIACLONE and the mAbexperts Group will be present at the 4st edition of “Bioproduction des Immunothérapies” organized by Mabdesign at BIOCITECH – Romainville (FR) – September 24th, 2019. Read more
  • Munich
    German Society for Immunology (DGfl)
    Publication date : 2019-08-28
    DIACLONE and the mAbexperts Group will be present at the German society meeting for Immunology (DGfl) » - Munchen (Germany) – September 10th to 13th 2019. Read more
  • Diaclone est partenaire d’un projet européen d’envergure associant une douzaine de partenaires de la région de Besançon.
    MiMédi Project
    Publication date : 2019-08-29
    Diaclone is a partner in a major European project involving a dozen partners from the Besançon region. Read more
  • New Diaclone Catalogue!
    New Diaclone Catalogue
    Publication date : 2019-09-05
    Diaclone is pleased to present its new catalogue! Just click and discover.... Read more
  • 1ères journées du Club Anticorps de la Société Française d’immunologie.
    2ème journée du Club Anticorps de la Société Française d'Immunologie
    Publication date : 2019-09-13
    DIACLONE est partenaire et co-organisateur de la 2ème journée du Club Anticorps de la Société Française d'Immunologie ! Read more

Product search